# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-008927
Filing Date
2020-05-15
Accepted
2020-05-15 08:44:28
Documents
75
Period of Report
2020-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm | 10-Q | 1145259
2 |  | ex31-1.htm | EX-31.1 | 20049
3 |  | ex31-2.htm | EX-31.2 | 20369
4 |  | ex32-1.htm | EX-32.1 | 8800
| Complete submission text file | 0001493152-20-008927.txt |  | 4428809

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE FILE | clsn-20200331.xml | EX-101.INS | 563345
6 | XBRL SCHEMA FILE | clsn-20200331.xsd | EX-101.SCH | 67336
7 | XBRL CALCULATION FILE | clsn-20200331_cal.xml | EX-101.CAL | 75066
8 | XBRL DEFINITION FILE | clsn-20200331_def.xml | EX-101.DEF | 208938
9 | XBRL LABEL FILE | clsn-20200331_lab.xml | EX-101.LAB | 424453
10 | XBRL PRESENTATION FILE | clsn-20200331_pre.xml | EX-101.PRE | 304899

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 20880813
SIC: 2834 Pharmaceutical Preparations